Oral nucleoside antiviral is progressing toward future pandemic preparedness
Obeldesivir (GS-5245), a novel investigational small molecule oral antiviral, represents a new tool in the ongoing effort to prepare for future pandemics. Several researchers at the University of North Carolina at Chapel Hill’s Gillings School of Global Public Health are co-authors of a new study published online May 22 by the journal Science Translational Medicine. … Read more
